Intrinsic Therapeutics is a medical device company focused on developing innovative therapies that address the spine market's many unmet clinical needs. The company's first product, Barricaid, is a revolutionary spinal implant that was developed to treat patients undergoing surgery for herniated lumbar discs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/08/12 | $11,700,000 | |||
| 05/11/17 | $28,000,000 |
Delos Capital Quadrille Capital | undisclosed |
